Thrombus composition in acute ischemic stroke: A histopathological study of thrombus extracted by endovascular retrieval

Journal of Neuroradiology

Volumn 42, Issue 2, 2015, Pages 86-92

  Simons, Natasha ^a   Mitchell, Peter ^a   Dowling, Richard ^a   Gonzales, Michael ^a   Yan, Bernard ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Ischaemia; Stroke; Thrombolysis; Thrombus; Thrombus retrieval

Indexed keywords

ALTEPLASE; FIBRIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; ERYTHROCYTE; FEMALE; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERDENSE ARTERY SIGN; HYPERTENSION; MALE; NEUROIMAGING; NEUROLOGICAL THERAPEUTIC DEVICE; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; REVASCULARIZATION DEVICE; THROMBUS; THROMBUS ASPIRATION; TRANSIENT ISCHEMIC ATTACK; BIOPSY; CLINICAL TRIAL; ENDOVASCULAR SURGERY; INTRACRANIAL THROMBOSIS; PATHOLOGY; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; STROKE; THROMBECTOMY; THROMBOSIS;

AGED; BIOPSY; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; STROKE; THROMBECTOMY; THROMBOSIS;

EID: 84926410449     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2014.01.124     Document Type: Article

References (33)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587.
2. Clark W.M., Wissman S., Albers G.W., et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute non-interventional therapy in ischemic stroke. JAMA J Am Med Assoc 1999, 282:2019-2026.
3. American Heart Association Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38:1655-1711.
4. European Stroke Organisation Guidelines for management of ischemic stroke and transient ischemic attack 2008-The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovasc Dis 2008, 25:457-507.
5. Bhatia R., Hill M.D., Shotha N., et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010, 41:2254-2258.
6. Jang I.K., Gold H.K., Ziskind A.A., et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation 1989, 79:920-928.
7. Blinc A., Planinsic G., Keber D., et al. Dependence of blood thrombus lysis on the mode of transport of urokinase into the thrombus-a magnetic resonance imaging study in vitro. Thromb Haemost 1991, 65:549-552.
8. Blinc A., Keber D., Lahajnar G., et al. Magnetic resonance imaging of retracted and non-retracted blood thrombi during fibrinolysis in vitro. Haemostasis 1992, 22:195-201.
9. Wu J.H., Siddiqui K., Diamond S.L. Transport phenomena and thrombus dissolution therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis. J Thromb Haemost 1994, 72:105-112.
10. Niessen F., Hilger T., Hoegn M., et al. Differences in thrombus preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 2003, 34:2019-2024.
11. Kirchhof K., Welzel T., Mecke C., et al. Differentiation of white, mixed, and red thrombi: value of CT in estimation of the prognosis of thrombolysis-Phantom Study1. Radiology 2003, 228:126-130.
12. Kirchhof K., Sikinger M., Welzel T., et al. Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?. Rofo 2004, 176:98-105.
13. Marder V., Chute D., Starkman S., et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006, 37:2086-2093.
14. Young B., Stewart W., O'Dowd G. Wheater's basic pathology: A text atlas and review of histopathology 2011, 95-98. Churchill Livingstone Elsevier, Philadelphia. 5th.
15. Friedman M., Bovenkamp G.J.V. The pathogenesis of a coronary thrombus. Am J Pathol 1966, 48:19-44.
16. Jorgensen L. Experimental platelet and coagulation thrombi: a histological study of arterial and venous thrombi of varying age in untreated and heparinized rabbits. Acta Pathol Microbiol Immunol Scand 1964, 62:189-223.
17. Sirol M., Fuster V., Badimon J., et al. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005, 112:1594-1600.
18. Pusztaszeri M.P., Seelentag W., Bosman F.T. Immunohistochemical expression of endothelial markers CD31, CD34, von Willenbrand Factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006, 54:385.
19. Muller A.M., Hermanns M.I., Skrzynki C., et al. Expression of the endothelial markers PECAM-1, VWf and CD34 in vivo and in vitro. Exp Mol Pathol 2002, 72:221-229.
20. Wardlaw J.M., del Zoppo G., Yamaguchi T., et al. Thrombolysis for acute ischemic stroke. Stroke 2004, 35:2914-2915.
21. Hacke W., von Kummer R., Donnan G., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363:768-774.
22. Raoult H., Eugene F., Ferre J.C., et al. Prognostic factors for outcomes after mechanical thrombectomy with solitaire stent. J Neuroradiol 2013, 40(4):252-259.
23. Lovblad K.O., Altrichter s, Viallon M., et al. Neuro-imaging of cerebral ischemic stroke. J Neuroradiol 2008, 35(4):197-209.
24. Soize S., Kadziolka K., Estrade L., et al. Outcome after mechanical thrombectomy using a stent retriever under conscious sedation: Comparison between tandem and single occlusion of the anterior circulation. J Neuroradiol 2013.
25. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993, 24:35.
26. Liebeskind D., Sanossian N., Yong W., et al. CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011, 42:1237-1243.
27. Kirchhof K., Welzel T., Zoubaa S., et al. New method of embolus preparation for standardized embolic stroke in rabbits. Stroke 2002, 33:2329-2333.
28. Almekhlafi M.A., Hu W.Y., Hill M.D., et al. Classification and endothelialisation of thrombi in acute ischemic stroke. Ann Neurol 2008, 64:344-348.
29. Molina C.A., Montaner J., Arenillas J.F., et al. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004, 35:486-490.
30. Ogata J., Yutani C., Otsubo R., et al. Heart and vessel pathology underlying brain infarction in 142 stroke patients. Ann Neurol 2008, 63:770.
31. Sato Y., Ishibashi Ueda H., Iwakiri T., et al. Thrombus components in cardioembolic and atherothrombotic strokes. Thromb Res 2012, 130:278-280.
32. Minnerup J. Visualization of clot composition in ischemic stroke do we get what we see?. Stroke 2011, 42:1193.
33. Yilmaz U., Roth C., Reith W., et al. Thrombus attenuation does not predict angiographic results of mechanical thrombectomy with stent retrievers. AJNR Am J Neuroradiol 2013, 34(11):2184-2186.